Apricus Biosciences Revenue, Profits - APRI Quarterly Income Statement

Add to My Stocks
$0.29 $0.01 (3.57%) APRI stock closing price Oct 12, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Apricus Biosciences stock price. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. Like any other income statement, the APRI income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a QoQ revenue decline of 0 when compared to the same period in the past. Along with Apricus Biosciences assets and Apricus Biosciences free cash flow, Apricus Biosciences profits as shown in profit and loss statement give key insights about the business. The net profit for 2018 Q2 is $-2.28M and the 2018 Q2 revenue is $-.

View and download details of revenue and profits for Apricus Biosciences for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q2
Apricus Biosciences Revenues or Net Sales
-------4.32M-
Cost Of Goods Sold (COGS)-------3.49M-
Apricus Biosciences Gross Profit
---------
Research & Development Expense---1.96M----2.78M
Selling General & Admin Expense2.07M2.13M2.42M1.75M1.6M1.44M1.94M1.81M2.29M
Income Before Depreciation Depletion Amortization-2.23M-2.35M-2.67M-3.71M-2.44M-1.85M-2.49M-1.39M-4.71M
Depreciation Depletion Amortization---------
Non Operating Income-0.01M---0.29M--1.55M2.42M-1.63M
Interest Expense---------
Apricus Biosciences Pretax Income
-2.25M-2.27M-2.62M-4M-1.72M-3.4M-0.31M-1.29M-3.33M
Provision for Income Taxes---------
MinorityInterest---------
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations-2.25M-2.27M-2.4M-4.01M-1.72M-3.4M-0.3M-1.29M-3.34M
Extraordinary Items & Discontinued Operations-0.02M----11.48M---
Apricus Biosciences Profit/ Loss (Net Income)
-2.28M-2.27M-2.4M-3.83M-1.47M8.07M-0.3M-1.29M-3.34M
Average Shares used to compute Diluted EPS23.36M15.97M15M13.21M11.34M7.74M7.5M6.63M6.18M
Average Shares used to compute Basic EPS23.36M15.97M15M13.21M11.34M7.74M7.5M6.63M6.18M
Income Before Nonrecurring Items-2.25M-2.27M-2.4M-4.01M-1.72M-3.4M-0.3M-1.29M-4.94M
Income from Nonrecurring Items--------1.6M
Apricus Biosciences Earnings Per Share Basic Net
-0.10-0.14-0.16-0.29-0.131.04-0.04-0.19-0.50
Apricus Biosciences Earnings Per Share Diluted Net
-0.10-0.14-0.16-0.29-0.131.04-0.04-0.19-0.50
EPS Diluted Before Nonrecurring Items-0.10-0.14-0.16-0.30-0.15-0.44-0.04-0.19-0.80
Preferred Dividends Acc Pd---------
Dividends Common0.000.000.00------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

It is very helpful to read a report on Apricus Biosciences stock analysis. An investor must check the following items in an income statement:

  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth - See: Apricus Biosciences revenue chart, implies that the company is growing. It has not been the case with Apricus Biosciences. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. APRI stock had a poor bottom line growth.

The income statement is also called statement of revenue and expense. The APRI financials along with Apricus Biosciences historical stock prices provide a lot of details about the firm.

Apricus Biosciences Income Statement - Key Financial Ratios